Aimed Bio Inc. (KOSDAQ:0009K0)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,750
-1,400 (-6.62%)
At close: Jul 20, 2026
Market Cap1.28T
Revenue (ttm)54.20B +309.9%
Net Income4.07B
EPS71.35
Shares Out 64.67M
PE Ratio276.79
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume130,954
Open20,500
Previous Close21,150
Day's Range19,680 - 20,600
52-Week Range19,750 - 80,200
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Aimed Bio

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 0009K0
Full Company Profile

Financial Performance

Financial Statements